Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol-Lidocaine for Preventing Emergence Agitation in Pediatric Ophthalmic Surgeries
NCT07601698Phase 4Not yet recruiting
- Sponsor
- Sohag University
- Start
- May 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexmedetomidine, propofol injection (veterinary), Lidocaine Hydrochloride Injection, without epinephrine in Emergence agitation (EA), sponsored by Sohag University. Planned start May 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinepropofol injection (veterinary)Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07601698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07601698.